CopyMark Law Group
4.9
Drawing for AIC

USPTO serial 79430127

AIC

Reviewed by CopyMark Law Group

Reg. 8374657Status 700Registered
Filing date
Status date
Registration date
Aug 4, 2026
Examiner
JAGDEO, KARA CECILIA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals in the nature of pharmaceutical preparations for the treatment of viral infections; diagnostic preparations and materials, for medical and veterinary purposes; antibiotics; antifungal medication; anti-viral agents; anti-cancer drugs; immunomodulators being pharmaceutical preparations for stimulating or suppressing the human immune system; cellular function activating agents for medical purposes;; blood substitutes for medical purposes; blood protein fractions for medical purposes; enzyme preparations for veterinary purposes; enzymes for veterinary purposes; enzyme preparations for medical purposes; greases for medical or veterinary purposes; vaccines; stem cells for veterinary purposes; stem cells for medical purposes; blood plasmaACTIVE—
041Training services in the field of pharmaceutical and medical research and development; arranging and conducting of seminars in the field of pharmaceutical and medical research; teaching in the field of pharmacology; courses being training relating to science; publication of scientific information journals; non downloadable electronic publication in the nature of articles, brochures, abstracts and presentation slides in the field of pharmaceutical and medical researchACTIVE—
042Development of pharmaceutical preparations and medicines; pharmaceutical research services; pharmaceutical product evaluation; testing of pharmaceuticals; laboratory research in the field of pharmaceuticals; providing information technology services for the pharmaceutical and healthcare industries; providing medical research information in the field of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; conducting scientific research in the nature of clinical trials for pharmaceutical products for others; biological research, clinical surgery research and medical research; medical research laboratory services; scientific investigations for medical purposesACTIVE—
044Medical services; pharmaceutical compounding services; medical screening; medical diagnostic services; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to medical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 4, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2026GPNXNOTIFICATION PROCESSED BY IB—
Jun 10, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 27, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 16, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 27, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 7, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 7, 2026RFRRREFUSAL PROCESSED BY MPU—
Nov 30, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2025DOCKASSIGNED TO EXAMINER—
Aug 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 14, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance